Diabetic nephropathy

M. E. Molitch; R. A. DeFronzo; M. J. Franz; W. F. Keane; C. E. Mogensen; H. H. Parving; M. W. Steffes

Diabetic nephropathy

M. E. Molitch, R. A. DeFronzo, M. J. Franz, W. F. Keane, C. E. Mogensen, H. H. Parving, M. W. Steffes

Producción científica: Review article › revisión exhaustiva

Resumen

Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

Idioma original	English (US)
Páginas (desde-hasta)	S69-S72
Publicación	Diabetes care
Volumen	23
N.º	1 SUPPL.
Estado	Published - ene 2000
Publicado de forma externa	Sí

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Advanced and Specialized Nursing

Otros archivos y enlaces

Citar esto

@article{cbf220472497416c8da8888fbe738191,

title = "Diabetic nephropathy",

abstract = "Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.",

author = "Molitch, {M. E.} and DeFronzo, {R. A.} and Franz, {M. J.} and Keane, {W. F.} and Mogensen, {C. E.} and Parving, {H. H.} and Steffes, {M. W.}",

year = "2000",

month = jan,

language = "English (US)",

volume = "23",

pages = "S69--S72",

journal = "Diabetes care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "1 SUPPL.",

}

TY - JOUR

T1 - Diabetic nephropathy

AU - Molitch, M. E.

AU - DeFronzo, R. A.

AU - Franz, M. J.

AU - Keane, W. F.

AU - Mogensen, C. E.

AU - Parving, H. H.

AU - Steffes, M. W.

PY - 2000/1

Y1 - 2000/1

N2 - Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

AB - Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of ACE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

UR - http://www.scopus.com/inward/record.url?scp=0033958407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033958407&partnerID=8YFLogxK

M3 - Review article

C2 - 12017684

AN - SCOPUS:0033958407

SN - 0149-5992

VL - 23

SP - S69-S72

JO - Diabetes care

JF - Diabetes care

IS - 1 SUPPL.

ER -

Diabetic nephropathy

Resumen

ASJC Scopus subject areas

Otros archivos y enlaces

Huella

Citar esto